Skip to main content
. Author manuscript; available in PMC: 2017 Mar 29.
Published in final edited form as: Circulation. 2016 Feb 12;133(13):1240–1248. doi: 10.1161/CIRCULATIONAHA.115.020207

Table 1.

Clinical characteristics of patients stratified by referent, borderline pulmonary hypertension (PH), and PH status.

Clinical Variable mPAP (mmHg) P Value
≤18 (N=4207) 19–24 (N=5030) ≥25 (N=12490)
Age (yr) 64.3 [59.6–73.0] 65.2 [60.3–73.5] 64.9 [60.2–73.4] <0.0001
Sex (M) 96.5 (4059) 96.6 (4861) 96.6 (12071) 0.8730
Race <0.0001
 White 79.1 (3328) 79.3 (3987) 73.4 (9166)
 Black or African American 12.0 (506) 13.1 (659) 19.3 (2405)
 Other 8.9 (373) 7.6 (384) 7.3 (919)
Body Mass Index (BMI) 28.0 [24.6–31.5] 29.6 [26.0–34.0] 30.6 [26.3–35.8] <0.0001
BMI Categorized <0.0001
 Normal (18.5–24.9kg/m2) 26.2 (1103) 18.0 (906) 17.1 (2138)
 Underweight (<18.5 kg/m2) 1.4 (57) 1.1 (53) 1.0 (125)
 Overweight (25–29.9 kg/m2) 38.7 (1628) 33.6 (1692) 28.8 (3603)
 Obese (≥30 kg/m2) 33.7 (1419) 47.3 (2379) 53.0 (6624)
Systemic hypertension 82.3 (3462) 86.0 (4327) 89.8 (11221) <0.0001
Left heart failure 4.8 (201) 6.6 (333) 15.5 (1939) <0.0001
Congestive heart failure 34.1 (1434) 42.7 (2146) 67.9 (8478) <0.0001
Diabetes 33.4 (1405) 40.6 (2043) 52.6 (6568) <0.0001
Coronary Summary <0.0001
 Normal 21.4 (779) 17.6 (754) 15.9 (1477)
 Non-Obstructive 33.0 (1200) 34.5 (1480) 30.9 (2872)
 1-vessel obstructive 16.9 (616) 17.7 (760) 17.7 (1645)
 2-vessel obstructive 11.8 (428) 12.5 (535) 13.5 (1255)
 3-vessel/LMCA obstructive 16.3 (593) 17.2 (739) 21.6 (2007)
 Other 0.7 (25) 0.6 (28) 0.6 (53)
COPD 23.0 (968) 30.8 (1548) 37.9 (4731) <0.0001
Interstitial lung disease 0.4 (18) 0.7 (37) 0.7 (93) 0.0840
Obstructive sleep apnea 7.3 (307) 10.2 (513) 14.9 (1858) <0.0001
HIV 0.5 (23) 0.3 (16) 0.5 (57) 0.2390
Sickle cell anemia* 0 (1) 0 (1) 0.1 (8)
Liver cirrhosis 9.7 (406) 8.1 (405) 8.7 (1083) 0.0242
Chronic kidney disease 17.6 (742) 21.2 (1065) 32.6 (4068) <0.0001
Connective tissue disease 4.9 (205) 4.3 (217) 3.7 (465) 0.0031

Clinical and hemodynamic data for patients undergoing right heart catheterization between 2007–2012 were accessed from the VA Clinical Assessment Reporting and Tracking Program (N=21,717) and patients were stratified into three groups according to mean pulmonary artery pressure (mPAP) level: referent (≤18 mmHg), borderline PH (19–24 mmHg), and PH (≥25 mmHg). COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; LMCA, left main coronary artery. Data are expressed as % (N) for categorical variables and median [interquartile range] for continuous variables.

*

A Chi-squared test was not performed in this case due to very low counts of individuals with this diagnosis.